Bay Harbor Wealth Management’s Teva Pharmaceuticals TEVA Stock Holding History

Bay Harbor Wealth Management’s Portfolio TEVA Stock Details TEVA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$33.9K	Buy	+1,000	New	+$33.3K	0.01%	168
2021 Q1	–	Sell	-77	Closed	-$1K	–	398
2020 Q4	$1K	Hold	77	–	–	﹤0.01%	400
2020 Q3	$1K	Hold	77	–	–	﹤0.01%	360
2020 Q2	$1K	Hold	77	–	–	﹤0.01%	330
2020 Q1	$1K	Hold	77	–	–	﹤0.01%	321
2019 Q4	$1K	Hold	77	–	–	﹤0.01%	327
2019 Q3	$1K	Sell	77 -34	-31%	-$260	﹤0.01%	345
2019 Q2	$1K	Buy	111 +34	+44%	+$410	﹤0.01%	341
2019 Q1	$1K	Hold	77	–	–	﹤0.01%	374
2018 Q4	$1K	Buy	+77	New	+$1.58K	﹤0.01%	367

Other funds holding TEVA

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

HIIFS

Harel Insurance Investments & Financial Services Ramat Gan, Israel $20.6B AUM 59.59% 1-Year Est. Return

Phoenix Financial Givatayim, Israel $14.6B AUM 57.48% 1-Year Est. Return

WCM Investment Management Laguna Beach, California $55.2B AUM 57.07% 1-Year Est. Return

Clal Insurance Tel-Aviv, Israel $22.3B AUM 79.91% 1-Year Est. Return

MMH

Menora Mivtachim Holdings Ramat Gan, Israel $25.6B AUM 50.04% 1-Year Est. Return

MIFH

Migdal Insurance & Financial Holdings Petach Tikva, Israel $15.6B AUM 71.29% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

LIM

Lingotto Investment Management London, United Kingdom $4.67B AUM 70.24% 1-Year Est. Return

Bay Harbor Wealth Management's TEVA Position: Q2 2026 in Review

Bay Harbor Wealth Management opened a new position in Teva Pharmaceuticals (TEVA) in Q2 2026: 1,000 shares worth $33.9K. The stake represents 0.01% of the portfolio and ranks #168 among its holdings. This is a return to the name: Bay Harbor Wealth Management previously reported a position in TEVA as recently as Q4 2020.

Bay Harbor Wealth Management first reported a position in TEVA in Q4 2018 and has held it in 10 quarters since. 675 funds tracked by Wall St. Rank hold TEVA as of Q2 2026.

Bay Harbor Wealth Management held 1,000 shares of Teva Pharmaceuticals worth $33.9K as of Q2 2026.
Teva Pharmaceuticals was a new Bay Harbor Wealth Management position in Q2 2026.
Teva Pharmaceuticals made up 0.01% of Bay Harbor Wealth Management's portfolio in Q2 2026, its #168 holding.
Bay Harbor Wealth Management first reported a position in Teva Pharmaceuticals in Q4 2018 and has held it in 10 quarters since.
675 funds tracked by Wall St. Rank held Teva Pharmaceuticals as of Q2 2026.

Based on Bay Harbor Wealth Management's 13F filing for Q2 2026, filed 28 Jul 2026.